Clinical trial

SER100 in Isolated Systolic Hypertension

NCT01987284

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-10-01

PhasePHASE2

Study timeline

Study start (unknown)2013-10-01Date precision: month

Registry last updated2016-10-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Isolated Systolic Hypertensionunresolved

Interventions

SER100DRUG

PlaceboDRUG

Sponsors & collaborators

Serodus ASlead sponsor

Smerud Medical Research International AScollaborator

The Research Council of Norwaycollaborator

Mapped research locations

BudapestHungary1 OsloNorway1 TurkuFinland1 TampereFinland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01987284 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.